TAKE Solutions Hits 2% Upper Circuit After Launch of AI-Driven Digital Health Platform


By Dalal Street Investment Journal (DSIJ)

Summary:


TAKE Solutions shares surged after the launch of its AI-powered Take.Health platform, aimed at simplifying medical data and promoting preventive care. The platform offers lab analysis, health tracking, and wellness features. With India’s growing focus on digital healthcare and a large smartphone base, the company is positioning itself to tap into a high-growth, technology-driven healthcare market.

Why Fertilisers Could Be the Next Big Risk for Indian Stocks

Shares of TAKE Solutions came into sharp focus on Friday, March 27, 2026, as the stock hit its 2% upper circuit limit at ₹38.85. The trigger for the surge was the company’s announcement of its new AI-powered digital health platform, Take.Health.

Launch of Take.Health Platform

TAKE Solutions has introduced Take.Health as a comprehensive digital platform aimed at simplifying complex medical data into personalised and actionable health insights. The platform is designed to make healthcare more accessible and preventive in nature by leveraging artificial intelligence.

At its core, Take.Health provides a service that utilises AI for lab report analysis, which is helpful in easily understanding medical reports. It also provides a dynamic health dashboard that monitors vital health parameters such as vitamins, cholesterol, and blood sugar. Furthermore, it provides a predictive risk identification service.

Holistic Health and Wellness Integration

Beyond diagnostics, the platform provides a wide range of lifestyle and wellness features. These features include personalised nutrition and calorie intake management through personalised diet plans, in addition to condition-specific support for conditions such as diabetes. It further includes holistic wellness features that include activity tracking, supplements, and sleep tracking, in addition to in-depth analysis.

The company has strategically positioned itself to cater to both retail consumers and enterprise or workplace segments. This is likely to help the company generate revenue streams from both individuals and enterprises.

Riding India’s Preventive Healthcare Shift

The launch is well timed, given that the healthcare sector in India is witnessing a paradigm shift. There is a move from reactive care to preventive care, and people are increasingly focused on early detection, health monitoring, and lifestyle management.

Lifestyle-related health conditions, including diabetes, heart conditions, and sleep disorders, are on the rise. Added to this is the fact that India has a large base of over 600 million smartphone users.

Strong Market Opportunity

The potential in this area is quite high. The preventive healthcare market in India alone has been estimated to grow to over $197 billion by the year 2030. The overall healthcare market in the country has been estimated to grow to $370 billion.

Management Commentary

Parmeshvar Dhangare, Director of TAKE Solutions, highlighted the strategic importance of the launch. He stated that as healthcare transitions towards AI-led prevention and personalised wellness, Take.Health positions the company strongly in a high-growth and future-ready segment.

He added that the platform’s scalable, technology-driven model is expected to deepen the company’s presence in digital healthcare, unlock new revenue streams through subscription and data-led services, and enhance customer lifetime value through continuous engagement. It also enables the company to capitalise on the long-term convergence of healthcare, data analytics, and technology.

About TAKE Solutions

TAKE Solutions Limited is a global technology company that offers domain-intensive solutions in the life sciences and supply chain industries. It is a company that is dedicated to developing scalable digital solutions that are data-driven and improve efficiency and compliance.

With investments in AI, analytics, and digital health technologies, TAKE Solutions Limited has a global client base that includes innovator biopharmaceutical companies, medical devices companies, generics companies, and US federal agencies.

Conclusion

The launch of Take.Health represents a strategic move by TAKE Solutions into the expanding arena of digital and preventive healthcare. With the tailwinds of the healthcare industry and the scalable potential of the AI-driven platform, there is scope for the company to find new avenues of growth while further cementing itself in the healthcare technology segment.

About the Author

SEBI Registered Research Analyst (INH000006396).


Founded in 1986, Dalal Street Investment Journal (DSIJ) brings decades of experience in India’s equity markets. DSIJ's research combines fundamental analysis with price action, guided by disciplined risk management and capital preservation. They follow a structured, data-driven approach designed to help investors and traders make informed decisions beyond short-term market noise. 

Published Date : 27 Mar 2026

Disclaimer :

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.


Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 lakh+ Users

icon-with-text

4.7 App Rating

icon-with-text

4 Languages

icon-with-text

₹7,300+ Cr MTF Book

icon-with-text